Our Specialists

Mr. Like Wu, MD, Ph.D, the founder of Wu Medical Center, is one of the pioneers in the world with regards to using stem cells to treat patients with various difficult-to-treat medical conditions. During the course of his more than 30 years of clinical experience in neurology and internal medicine, he’s treated more than 30,000 patients. His laboratory research in stem cell started in 1987 and extended to clinical applications in late 90’s. The clinical stem cell technologies he invented include autologous stem cell activation, intracorporeal cell control and targeted localization.

These unique and advanced technologies have allowed Dr. Wu and his medical team to treat more than 7,000 patients with excellent outcome since the year 2000, representing a breakthrough progress in treating degenerative neurological diseases (motor neuron disease, Parkinson's disease, dementia and Friedreich ataxia, etc.) , nerve injuries (brain trauma, spinal cord injury and cerebral stroke, etc.), abnormal neurodevelopment(cerebral palsy, epilepsy and autism, etc.), certain type of eye diseases (retinal/macular/diseases/optic nerve diseases) and internal diseases (diabetes and renal insufficiency, etc) and bone/joint diseases.

Dr. Wu also published more than 40 papers and articles in various professional medical science journals.
 

Selected Publications:

1. Mechanisms of stem cell therapy in Amyotrophic Lateral Sclerosis (ALS).
--- Wu Medical Center Website, 2015, Like Wu, Xiaojuan Wang and Bo Cheng
2. Stem cell treatment analysis for motor neuron diseases.
--- Wu Medical Center Website, 2015, Like Wu, Bo Cheng, Xiaojuan Wang and Saichun Chu
3. Clinical study of neural stem cell transplantation for the treatment of spinal cord injury.
--- Wu Medical Center Website, 2014, Like Wu, Xiaojuan Wang and Bo Cheng
4. Stem cell treatment for autism.
--- Wu Medical Center Website, 2013, Like Wu, Xiaojuan Wang, Bo Cheng and Saichun Chu
5. Progress in stem cell treatment for cerebral palsy.
--- Wu Medical Center Website, 2012, Like Wu, Xiaojuan Wang Xinrui Xi, Chuangshuang Liu, Bo Cheng
and Saichun Chu
6. Cell viability and dopamine secretion of 6-hydroxydopamine-treated PC12 cells co-cultured with bone marrow-derived mesenchymal stem cells.
--- Neural Regeneration Research 7(14), 2012. Yue Tang, Xiaojuan Yue Tang, Yongchun Cui, Fuliang Luo, Xiaopeng Liu, Xiaojuan Wang, Aili Wu, Junwei Zhao, Zhong Tian and Like Wu
7. Umbilical cord blood mesenchymal stem cell transplantation in 20 patients with multiple system atrophy.
--- Journal of Clinical Rehabilitative Tissue Engineering Research. 2009,13(45):8975-8978. Like Wu, Xiaojuan Wang, Baolei Xu, Shuangshaung Liu and Saichun Chu
8. Umbilical cord blood mesenchymal stem cell transplantation for Parkinson disease in 30 patients.
--- Journal of Clinical Rehabilitative Tissue Engineering Research. 2009,13(40): 7951-7954. Like Wu, Xiaojuan Wang, Saichun Chu, Baolei Xu and Bo Cheng
9. Research progress of bone marrow stromal cells in the treatment of Parkinson's disease.
--- Elderly Medicine Fascicule of Overseas Medicine 2008, 29(4):181-184 Like Wu and Xiaoxjuan Wang
10. A case of using stem cells to treat injuries of spinal cord sequela.
--- China Health News p6, June 25, 2006 Like Wu and Xiaoxjuan Wang
11. Aminoguanidine of NOSI can protect the cerebral ischemia of rats: Chinese Clinical Medicine Research Magazine.
--- Chinese Journal of Clinical Medicine Research. 2006, 26(6): 1-3. Like Wu, Chen Chen and Xiaoxjuan Wang.
12. MPO and NSE's active change in the brain of rats with cerebral ischemia.
--- Beijing Medical Journal. 2006, 28(8):35-37 Like Wu, Zhou Zhang, Xiaoxjuan Wang
13. New strategy in the use of stem cells to treat cerebrovascular disease sequela.
--- China Health News p4 December 5, 2005 Like Wu and Xiaoxjuan Wang
14. Effects of TNF post-receptor reaction to cerebral cysticercosis.
--- Journal of Basic and Clinical Medicine, 2005 25(3) 265-267. Like Wu and Xiaoxjuan Wang
15. Level of endometrial estrogen receptor, plasma estradiol and morphological changes after tubal ligation in rats.
--- Chinese Journal of Practical Medicine. 2002, Vol. 4 No 9 17-20. Chaoquan Wei, Huchang Zheng and Like Wu
16. Guidelines for the management of patients with acute ischemic stroke.
--- China Health News p6 April 2, 2002. Like Wu
17. Mitochondrial Encephalomyopathy - Chronic Progressive External Ophthalmoplegia syndrome.
--- Journal of Brain and Nervous Diseases. 1996 Vol. 4 No 6-10. Like Wu and Huang Yixin
18. NO and Epilepsy research progress.
--- Henan Practical Neurological Journal. 2003 Vol. 6 No 2:126-130. Like Wu et al.
19. Practical value of SEP and SNAP in the diagnosis of Brachial Plexus (preganglionic or postganglionic) injury.
--- Journal of Modern Electrophysiology. 2001, No 14: 18-20. Like Wu and Yi Xing Huang et al.
20. The MPO level changes of ischemia reperfusion injury in rats.
--- Journal of Brain and Nervous Diseases. 2002 Vol. 10 No 2. Like Wu and Xueming Sheng
  

Dr. Wang is Associate Director and the Head Neurologist of the WSCMC. She is one of the China's most experienced researchers of stem cell treatment technology. She has learned from Professor Li Chunyan, the only neurology science academician in China and an expert of cerebrovascular disease. Dr. Wang has successfully treated cerebrovascular disease, neuro-degenerative diseases (such as Parkinson's Disease, dementia, etc), and demyelinating diseases (such as MS, optic neuritis, etc). Dr. Wang has rich experience of the stem cell treatment for brain injury and spinal cord injury. She has done the research work for the Hebei Natural Science Foundation project "Establishment of Organotypic Culture Model of Spinal Cord for Amyotrophic Lateral Sclerosis" and for another project "Effect of Estrogen on Neural Stem Cell's Proliferation and Differentiation Post Cerebral Ischemia". Dr. Wang has done research in the area of motor neuron disease and brain protection therapy post cerebral ischemia in collaboration with Johns Hopkins University (USA). She has published more than 40 research articles on diabetes, cardiac and cerebral vascular diseases as well as on treating patients in crisis situations. Dr. Wang is a member of the Chinese Medical Association, China Physicians Association, World Brilliant Chinese Association, and the Distinguished Researcher of China Science Management Committee.
 
2001-2004: PhD of Medical Science: Hebei Medical University.
1999-2001: Masters Degree of Medicine:Capital University of Medical Science.
1989-1994: Degree of Medicine: Nanjing Medical University.
Work Experience:
2008-Present: Wu Stem Cells Medical Centre: Director of Neurology Department.
2005-2008: Beijing Tiantan Puhua Hospital: Director of Neurology Department.
2004-2005: Beijing Tong Ren Hospital: Attending Neurologist.
1994-2004: Affiliated Central Hospital of Tianjin Medical University:Resident and attending Neurologist
 
Research Experience:
2007- Clinical study with two types of stem cells to treat Parkinson's disease.
Major project of Beijing's Science and Technology Commission.
2002-2005: Clinical study and industrialization of stem cells. Special major project. Beijing's Science Commission.
2001-2004: Stem cell and neurological degeneration diseases.
1998-2001: Cerebral Ischemia and brain injury .
 
Memberships:
Member of the Chinese Medical Doctors Association.
Chinese Medical Association .
World Brilliant Chinese Association.
 
Prizes and Awards:
Hebei Province Natural Science Foundation.
Hebei Province Planning Foundation.
 
Books: Neurology
Diabetes, Cardiac and Cerebral Vascular Diseases.
The Treatment of Emergency and Crisis Patients.
Papers Published:
1. Research progress of bone marrow stromal cells for the treatment of Parkinson's disease. Like Wu and Xiaoxjian Wang. Overseas Medicine, Elderly Medicine (fascicule of overseas medicine). 008,29(4):181-184.
2. Having the chance to use stem cells to treat injuries of spinal cord sequela.  Like Wu and Xiaoxjian Wang, Health Report, 2006, (9), No 4.
3. Aminoguanidine of NOSI can protect the cerebral ischemia of rats. Chinese Clinical Medicine Research Magazine, Like Wu, Chen Chen, Xiaoxjian Wang. 2006,26(6): 1-3.
4. MPO and NSE's active change in the brain of rats with cerebral ischemia. Like Wu, Zhou Zhang, Xiaoxjian Wang, Beijing Medicine, 2006,28(8):35-37.
5. New strategy in the use of stem cells to treat cerebrovascular disease sequela.    Like Wu and Xiaoxjian Wang, Healthy Newspaper, 2005 12, No 4.
6. Effects of GDNF on the survival and axon growth of dorsal root ganglion neurons of rats in vitro. Xiaojuan Wang, Guo Li, Liqin Wang, et al. Basic Medical Sciences and Clinics. 2003,123 (6) 629-634.
7. Effects of Glutamate Transport Inhibitor on organotypic cultured spinal cord splice. Xiaoxjian Wang, et al. Acta Biologiae Experimentalis Sinica, 2005 vol. 38 171-176.
8. Establishment of Organotypic Culture Model of Spinal Cord for Amyotrophic Lateral Sclerosis, Weigang Liu, Xiaojuan Wang, et al. Chinese Journal of Cell Biology 2004 ,26: 635-639.
9. A study of organotypic spinal cord splice culture and histochmical identification. Wang Xiaojuan, Song Xueqin, et al. Beijing Medicine (27) 162-166.
 
10. NO and Epilepsy research progress. Like Wu, et al. Henan Practical Neurological Journal, 2003 Vol. 6 No 2.
 
11. Practical value of SEP and SNAP in the diagnosis of Brachial Plexus (Preganlionic or postganglionic) injury. Like Wu, Yi Xing Huang, et al. Modern Electricity Physiology Journal.
 
12. The MPO level changes of ischemia reperfusion injury in rats. Like Wu, Xueming Sheng. The Journal of Brain and Neurological Disease, 2002 Vol. 10 No2.
 
 
Yonglian Zhu, MD, Professor
Chief of Neurorehabilitation Department at Chinese Rehabilitation Research Center. He had been the director of Beijing Neurosurgery Research Institute. Editor of Chinese Journal of Physical Medicine and Rehabilitation, he is the member of editorial board of Chinese Journal of Neurology.
Xiuqin Liu, MD, Professor.
She has been the Director of Neurology Department of Peking Union Medical College Hospital. Member of Chinese Medical Association. Editor of Chinese Journal of Neurology and Journal of Modern Electrophysiology.
Zhuo Zhang, MD, Professor
He is Director of Neurology Department of Peking Anzhen Hospital. Deputy Director of Neurology Section of Capital University of Medical Sciences. Subeditor of Beijing Journal of Medicine.
Huafeng Yu, MD, Master Tutor
He is director of Neurology Department of Beijing Tongren Hospital, Deputy Director of the fourth Neurology Section of Capital University of Medical Sciences.
Tianfeng Chen, MD
He has been Director of Neurology Department of Beijing Chaoyang Hospital, member of Beijing Neurology Institute of Chinese Medical Association (CMA). Editor of Journal of Cerebrovascular Diseases.
Mingwei Wang,MD, Professor
He is Deputy President of The First Affiliated Hospital of Hebei Medical University, Director of Neurology Department. Director of Neural Stem Cell Research Center of Hebei Medical University. Post Doctorate of University of Pittsburgh USA. He is chairman of Hebei Gerontology Institute.

 

Send Your Enquiry     Contact Us     Sitemap     Help

Copyright @2014 www.wumedicalcenter.com All rights reserved.
abuse@anti-spam.cn